Next 10 |
2024-05-06 08:26:44 ET More on pre-market losers & stocks. GameStop: Approaching An Optimistic Fair Value But Not There Yet GameStop: Operations Are Stabilizing, But Expect More Pain To Come Predictive Oncology Inc. (POAI) Q4 2023 Earnings Call Transcript ...
2024-04-18 08:15:07 ET Losers: Lithium Americas Corp LAC -24% on plans for 55M-share offering . NRX Pharmaceuticals NRXP -22% announces proposed underwritten public offering of common stock . Canaan CAN -22% files for $300M mixed shelf offering . Ic...
2024-04-16 08:28:48 ET More on pre-market losers & stocks. Financial information for Houston American Energy Financial information for Indonesia Energy Financial information for Organovo Holdings Compare metrics for HUSA to INDO, ONVO Read the f...
A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) rose 5.1% to $11.44 on volume of 198,678,404 shares Trio Petroleum Corp. (TPET) rose 22.1% to $0.63 on volume of 179,140,668 shares Soligenix Inc. (SNGX) rose 21.7% to $0.47 on volume of 133,754,026 shares Sup...
A look at the top 10 most actives in the United States Soligenix Inc. (SNGX) rose 127.5% to $0.8782 on volume of 62,157,057 shares Trio Petroleum Corp. (TPET) rose 8.0% to $0.5571 on volume of 48,902,033 shares Organovo Holdings Inc. (ONVO) rose 36.3% to $1.3769 on volume of 34,819,187 sh...
2024-04-15 09:05:46 ET DENVER, Colo., Apr 15, 2024 ( 247marketnews.com )- Organovo Holdings, Inc. (NASDAQ: ONVO ) reported complete details of its 16-week, randomized, placebo-controlled, multi-center Phase 2 study of the non-steroidal, non-bile acid FXR agonist FXR314 for the treat...
2024-04-15 08:51:23 ET More on Organovo Holdings Financial information for Organovo Holdings Read the full article on Seeking Alpha For further details see: Organovo reports positive mid-stage results for FXR314 in metabolic dysfunction-associated steatohepatitis
SAN DIEGO, April 15, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D) human tissues, today released the complete details of i...
2024-04-12 17:25:10 ET More on Organovo Holdings Financial information for Organovo Holdings Read the full article on Seeking Alpha For further details see: Organovo files to sell common stock, warrants
Turnstone Biologics Corp. (TSBX) is expected to report $-0.73 for Q4 2023 Exro Technologies Inc (EXROF) is expected to report for Q4 2023 Boyd Gaming Corporation (BYD) is expected to report $1.43 for Q4 2023 Onto Innovation Inc. (ONTO) is expected to report $0.99 for Q4 2023 Motor...
News, Short Squeeze, Breakout and More Instantly...
Organovo Holdings Inc. Company Name:
ONVO Stock Symbol:
NASDAQ Market:
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the P...
A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) rose 5.1% to $11.44 on volume of 198,678,404 shares Trio Petroleum Corp. (TPET) rose 22.1% to $0.63 on volume of 179,140,668 shares Soligenix Inc. (SNGX) rose 21.7% to $0.47 on volume of 133,754,026 shares Sup...
Organovo Holdings, Inc. (NASDAQ:ONVO) shares are trading higher Monday after the company announced Phase 2 results for FXR314. The Details: O...